Updates
Stay informed on recent developments in the world of biomarkers for bladder cancer surveillance
What is the place of urinary markers in NMIBC follow-up?
Watch the webinar by Prof. Fred Witjes On Thursday 21 January 2021, MML-Medical, partner of Nucleix in the Netherlands, organised the webinar “Follow-up of NMIBC, including the place of urinary markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred...
Epigenetic marker for the monitoring of bladder tumours
Watch the presentation of Dr. Fernando Lozano Palacio (Barcelona, Spain) During the virtual VI Symposium Liquid Biopsy, organised from 25 till 27 January 2021 by a scientific committee from the University Hospital of Santiago (Spain), Dr. Fernando Lozano Palacio from...
EAU guidelines: Evolving towards an additional role of biomarkers
Watch the editorial comment by Prof. Dr. Paolo Gontero on biomarker statements in the new EAU 2020 guidelines. Prof. Dr. Paolo Gontero is Professor of Urology at the University of Turin School of Medicine and Chairmen of the Division of Urology at the San Giovanni...
Webinar on Bladder EpiCheck®, for NMIBC monitoring
On Tuesday October 6th 2020, Nucleix, Israel and Palex Medical, Spain organised the webinar “Bladder EpiCheck®, for accurate, non-invasive bladder cancer monitoring”. Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands,...
Interested in the place of urinary markers in NMIBC follow-up?
Watch a webinar by Prof. Fred Witjes On Thursday 24 September 2020, Nucleix, Israel and Oncotest-Rhenium, Israel organised the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes,...
Methylation-based assay & TPS reporting of urine cytology
Reviewed by Joost Boormans (Erasmus MC Cancer Institute, Rotterdam, the Netherlands) Data from a recent study support the use of a urinary methylation-based assay, i.e. Bladder EpiCheck®, to accurately identify recurrence in patients with high-grade...